C
Chalice Brands Ltd.
OTC:CHALF
Chalice Brands Ltd.
OTC:CHALF
Price:
0.0001
USD
Market Closed
Market Cap:
$2.9m
Relative Value
There is not enough data to reliably calculate the relative value of CHALF.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CHALF
Relative Value
Base Case
Not Available
C
Multiples Across Competitors
CHALF Competitors Multiples
Chalice Brands Ltd. Competitors
Chalice Brands Ltd. Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
C
|
Chalice Brands Ltd.
OTC:CHALF
|
19m USD | 0.4 | -1.3 | -14.5 | -6.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
965.7B USD | 14.8 | 46.8 | 31.5 | 33.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
594B USD | 6.3 | 22.2 | 15.4 | 18.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
291.5B CHF | 4.8 | 31 | 13.1 | 15.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.4B GBP | 5.5 | 31.6 | 17.4 | 24.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
242.5B CHF | 5.5 | 22.3 | 13.8 | 17.7 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.7B USD | 4.7 | 16.6 | 10.4 | 12.2 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.3 | 9.7 | 11.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD | 2.4 | 19.6 | 7.3 | 9.8 | |
| UK |
|
GSK plc
XETRA:GS71
|
105.9B EUR | 2.8 | 16.1 | 8.1 | 11.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
